Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
New approaches to treatment of metastatic bladder cancer.
M. J. Edelman
Hematology Oncology
Cancer Signaling and Microenvironment (CSM)
University of Maryland Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New approaches to treatment of metastatic bladder cancer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Therapeutic Procedure
100%
Cisplatin
100%
Methotrexate
100%
Doxorubicin
100%
Vinblastine
100%
Metastatic Bladder Cancer
100%
Patient
33%
Combination Therapy
33%
Disease
33%
Transitional Cell Carcinoma
33%
Chemotherapeutic Agent
33%
Drug
33%
Experience
33%
Toxicity
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Doxorubicin
100%
Bladder Cancer
100%
Methotrexate
100%
Vinblastine
100%
Diseases
33%
Drug
33%
Toxicity
33%
Antiinfective Agent
33%
Transitional Cell Carcinoma
33%
Immunology and Microbiology
Bladder
100%
Methotrexate
100%
Experience
33%
Carcinoma Cell
33%
Biochemistry, Genetics and Molecular Biology
Methotrexate
100%